148 related articles for article (PubMed ID: 38240988)
1. Performance evaluation of Bruker UMIC
Bianco G; Boattini M; Comini S; Gaibani P; Cavallo R; Costa C
Eur J Clin Microbiol Infect Dis; 2024 Mar; 43(3):559-566. PubMed ID: 38240988
[TBL] [Abstract][Full Text] [Related]
2. Performance evaluation of the UMIC® Cefiderocol to determine MIC in Gram-negative bacteria.
Dortet L; Niccolai C; Pfennigwerth N; Frisch S; Gonzalez C; Antonelli A; Giani T; Hoenings R; Gatermann S; Rossolini GM; Naas T
J Antimicrob Chemother; 2023 Jul; 78(7):1672-1676. PubMed ID: 37209112
[TBL] [Abstract][Full Text] [Related]
3. Disc Diffusion and ComASP
Bianco G; Boattini M; Comini S; Banche G; Cavallo R; Costa C
Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978470
[TBL] [Abstract][Full Text] [Related]
4. Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis.
Karakonstantis S; Rousaki M; Vassilopoulou L; Kritsotakis EI
Clin Microbiol Infect; 2024 Feb; 30(2):178-188. PubMed ID: 37666449
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin-Tazobactam Susceptibility Testing of
García-Fernández S; Bala Y; Armstrong T; García-Castillo M; Burnham CA; Wallace MA; Hardy D; Zambardi G; Cantón R
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31597745
[TBL] [Abstract][Full Text] [Related]
6. Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints.
Bobenchik AM; Deak E; Hindler JA; Charlton CL; Humphries RM
J Clin Microbiol; 2017 Feb; 55(2):450-456. PubMed ID: 27881616
[TBL] [Abstract][Full Text] [Related]
7. Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
Delgado-Valverde M; Conejo MDC; Serrano L; Fernández-Cuenca F; Pascual Á
J Antimicrob Chemother; 2020 Jul; 75(7):1840-1849. PubMed ID: 32277821
[TBL] [Abstract][Full Text] [Related]
8.
Karlowsky JA; Hackel MA; Takemura M; Yamano Y; Echols R; Sahm DF
Antimicrob Agents Chemother; 2022 Feb; 66(2):e0199021. PubMed ID: 34807757
[TBL] [Abstract][Full Text] [Related]
9. Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing.
Matuschek E; Longshaw C; Takemura M; Yamano Y; Kahlmeter G
J Antimicrob Chemother; 2022 May; 77(6):1662-1669. PubMed ID: 35289853
[TBL] [Abstract][Full Text] [Related]
10. Performance of the Disc Diffusion Method, MTS Gradient Tests and Two Commercially Available Microdilution Tests for the Determination of Cefiderocol Susceptibility in
Jeannot K; Gaillot S; Triponney P; Portets S; Pourchet V; Fournier D; Potron A
Microorganisms; 2023 Jul; 11(8):. PubMed ID: 37630529
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan.
Hsueh SC; Lee YJ; Huang YT; Liao CH; Tsuji M; Hsueh PR
J Antimicrob Chemother; 2019 Feb; 74(2):380-386. PubMed ID: 30357343
[TBL] [Abstract][Full Text] [Related]
12.
Shortridge D; Streit JM; Mendes R; Castanheira M
Microbiol Spectr; 2022 Apr; 10(2):e0271221. PubMed ID: 35262394
[TBL] [Abstract][Full Text] [Related]
13. Comparative activity of antimicrobials against
Spierer O; Miller D; O'Brien TP
Br J Ophthalmol; 2018 May; 102(5):708-712. PubMed ID: 29459431
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cefiderocol disk diffusion versus broth microdilution results when tested against
Liu Y; Ding L; Han R; Zeng L; Li J; Guo Y; Hu F
Microbiol Spectr; 2023 Dec; 11(6):e0535522. PubMed ID: 37855593
[TBL] [Abstract][Full Text] [Related]
15. [Comparision of Colistin Broth Disc Elution, Rapid Resapolymyxin NP and Broth Microdilution Methods in Determining Colistin Sensitivity in Acinetobacter, Pseudomonas and Enterobacterales species].
Sarıkaya A; Mumcuoğlu İ; Baran I; Aksoy A; Dinç B
Mikrobiyol Bul; 2022 Jul; 56(3):404-415. PubMed ID: 35960234
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection.
Candel FJ; Santerre Henriksen A; Longshaw C; Yamano Y; Oliver A
Clin Microbiol Infect; 2022 Mar; 28(3):447.e1-447.e6. PubMed ID: 34298176
[TBL] [Abstract][Full Text] [Related]
17. Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales.
Bonnin RA; Emeraud C; Jousset AB; Naas T; Dortet L
Clin Microbiol Infect; 2022 Aug; 28(8):1156.e1-1156.e5. PubMed ID: 35533970
[TBL] [Abstract][Full Text] [Related]
18. Cefiderocol Antimicrobial Susceptibility Testing Considerations: the Achilles' Heel of the Trojan Horse?
Simner PJ; Patel R
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 32727829
[TBL] [Abstract][Full Text] [Related]
19. Performance of discs, sensititre EUMDROXF microplates and MTS gradient strips for the determination of the susceptibility of multidrug-resistant Pseudomonas aeruginosa to cefiderocol.
Devoos L; Biguenet A; Rousselot J; Bour M; Plésiat P; Fournier D; Jeannot K
Clin Microbiol Infect; 2023 May; 29(5):652.e1-652.e8. PubMed ID: 36587736
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Variability in Interpretation of Disk Diffusion Testing for Cefiderocol Using Different Brands of Mueller-Hinton Agar.
Potter RF; Wallace MA; Muenks CE; Alvarado K; Yarbrough ML; Burnham CD
J Appl Lab Med; 2023 May; 8(3):523-534. PubMed ID: 36738243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]